Breast screening in Singapore: Implications for pathology

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 10, 2007, Pages 827-833

  Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Borderline lesions; Quality assurance; Radiologic calcifications; Workload

Indexed keywords

ARTIFACT; BREAST BIOPSY; BREAST EXAMINATION; BREAST LESION; CALCIFICATION; CELL DAMAGE; CYTOLOGY; ECONOMIC ASPECT; HEALTH EDUCATION; HEALTH PROGRAM; HISTOLOGY; LABORATORY DIAGNOSIS; MAMMOGRAPHY; MEDICAL EDUCATION; MEDICAL STAFF; PROFESSIONAL STANDARD; QUALITY CONTROL; RADIOGRAPHY; REVIEW; SCREENING; WORKLOAD;

EID: 36148952147     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968-2002. Singapore Cancer Registry, 2004. Report No. 6.
2. Data from the Singapore Registry of Births and Deaths.
3. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am 2004;42:793-806.
4. Duffy SW, Tabar L, Chen HH. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95:458-69.
5. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, et al. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Cancer 1998;82:1521-8.
6. Tan PH, Chiang G, Ng EH, Low SC, Ng FC. Screen detected breast cancer in an Asian population: pathological findings of the Singapore breast screening project. Breast 1999;8:120-5.
7. Wang SC. The Singapore National Breast Screening Programme: principles and implementation. Ann Acad Med Singapore 2003;32: 466-76.
8. Royal College of Pathologists Working Party on Breast cancer Screening (Cytology Sub-committee). Guidelines for Cytology Procedures and Reporting in Breast Cancer Screening. Revised Edition. Sheffield: NHS Screening Publications, November 1993.
9. Chew I, Tan Y, Tan PH. Cytology is useful in breast screening: results and long-term follow-up of the Singapore Breast Screening Pilot Project. Cytopathology 2006;17:227-32.
10. Litherland JC. Should fine needle aspiration cytology in breast assessment be abandoned? Clin Radiol 2002;57:81-4.
11. Carder PJ, Liston JC. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate? J Clin Pathol 2003;56:133-8.
12. Liberman L, Tornos C, Huzjan R, Bartella L, Morris EA, Dershaw DD. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol 2006;186:1328-34.
13. Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 2004;122:440-3.
14. Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol 2004;122:217-21.
15. Fasih T, Jain M, Shrimankar J, Staunton M, Hubbard J, Griffith CD. All radial scars/complex sclerosing lesions seen on breast screening mammograms should be excised. Eur J Surg Oncol 2005;31:1125-8.
16. Kennedy M, Masterson AV, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003;56:721-4.
17. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 1993;23:225-31.
18. Jacobs TW, Chen YY, Guinee DG Jr, Holden JA, Cha I, Bauermeister DE, et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am J Clin Pathol 2005;124:342-54.
19. Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg 2003;138:987-90.
20. Carder PJ, Murphy CE, Liston JC. Surgical excision is warranted following a core biopsy diagnosis of mucocoele-like lesion of the breast. Histopathology 2004;45:148-54.
21. Pathology reporting of breast disease. NHS breast screening programme. NHSBSP publication no. 58. The Royal College of Pathologists. NHS Cancer screening programmes. Sheffield: NHS Screening Publications, 2005.
22. Crisi GM, Mandavilli S, Cronin E, Ricci A Jr. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003;27:325-33.
23. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002;117:797-9.
24. Tan PH, Ho JT, Ng EH, Chiang GS, Low SC, Ng FC, et al. Pathologic-radiologic correlations in screen-detected ductal carcinoma in situ of the breast: findings of the Singapore breast screening project. Int J Cancer 2000;90:231-6.
25. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-21.
26. Ho BC, Tan PH. Flat epithelial atypia: Concepts and controversies of an intraductal lesion of the breast. Pathology 2005;37:105-11.
27. Page DL, Dupont WD. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat 1993;28:157-66.
28. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
29. Tan PH. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding. Ann Acad Med Singapore 2001;30:671-7.
30. Shelley Hwang E, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004;100:2562-72.
31. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813-9.
32. Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy - clinical significance. Cancer 2004;101:242-50.
33. Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In: Tavassoli FA, Devilee P, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
34. Lim CN, Ho BC, Bay BH, Yip G, Tan PH. Nuclear morphometry in columnar cell lesions of the breast: is it useful? J Clin Pathol 2006;59: 1283-6.